tiprankstipranks
CK Life Sciences International (Holdings), Inc. (DE:LSI)
FRANKFURT:LSI
Germany Market
LSI
CK Life Sciences International (Holdings), Inc.
RESEARCH TOOLSreports

CK Life Sciences International (Holdings), Inc. (LSI) Ratios

1 Followers

CK Life Sciences International (Holdings), Inc. Ratios

DE:LSI's free cash flow for Q2 2026 was HK$0.14. For the 2026 fiscal year, DE:LSI's free cash flow was decreased by HK$ and operating cash flow was HK$0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.91 0.87 1.28 1.42 0.77
Quick Ratio
 0.51 0.51 0.78 0.85 0.45
Cash Ratio
 0.16 0.17 0.24 0.32 0.17
Solvency Ratio
 <0.01 -0.01 >-0.01 0.04 0.03
Operating Cash Flow Ratio
 -0.02 >-0.01 0.15 0.24 0.09
Short-Term Operating Cash Flow Coverage
 -0.03 -0.01 0.28 0.45 0.12
Net Current Asset Value
HK$ -4.97BHK$ -4.98BHK$ -4.31BHK$ -4.07BHK$ -3.99B
Leverage Ratios
Debt-to-Assets Ratio
 0.56 0.56 0.57 0.53 0.53
Debt-to-Equity Ratio
 1.73 1.75 1.74 1.42 1.43
Debt-to-Capital Ratio
 0.63 0.64 0.63 0.59 0.59
Long-Term Debt-to-Capital Ratio
 0.49 0.49 0.54 0.50 0.36
Financial Leverage Ratio
 3.08 3.13 3.07 2.68 2.71
Debt Service Coverage Ratio
 -0.04 -0.08 0.19 0.39 0.12
Interest Coverage Ratio
 -0.04 -0.51 2.32 0.69 1.35
Debt to Market Cap
 1.19 0.76 1.39 0.91 0.72
Interest Debt Per Share
 0.74 0.72 0.67 0.65 0.64
Net Debt to EBITDA
 82.55 -121.79 16.44 8.43 11.19
Profitability Margins
Gross Profit Margin
13.39%14.52%30.65%30.76%30.82%
EBIT Margin
-0.21%-2.50%4.45%7.35%6.97%
EBITDA Margin
1.38%-0.91%6.11%11.74%8.90%
Operating Profit Margin
-0.21%-2.50%14.18%4.21%4.16%
Pretax Profit Margin
1.78%-0.33%-1.66%1.29%3.88%
Net Profit Margin
-1.20%-3.48%-2.29%0.32%2.50%
Continuous Operations Profit Margin
-1.56%-3.48%-2.29%0.32%2.50%
Net Income Per EBT
-67.51%1046.29%138.34%25.15%64.41%
EBT Per EBIT
-868.03%13.31%-11.68%30.64%93.33%
Return on Assets (ROA)
-0.55%-1.59%-1.17%0.15%1.17%
Return on Equity (ROE)
-1.72%-4.99%-3.60%0.41%3.17%
Return on Capital Employed (ROCE)
-0.13%-1.62%9.24%2.45%3.05%
Return on Invested Capital (ROIC)
0.09%-1.25%7.97%0.54%1.37%
Return on Tangible Assets
-0.75%-2.22%-1.72%0.22%1.72%
Earnings Yield
-1.28%-2.39%-3.21%0.29%1.74%
Efficiency Ratios
Receivables Turnover
 5.87 5.56 5.05 5.96 5.31
Payables Turnover
 11.71 12.40 11.53 10.29 8.86
Inventory Turnover
 3.47 3.76 3.31 3.06 2.84
Fixed Asset Turnover
 1.94 1.99 2.15 1.94 2.03
Asset Turnover
 0.45 0.46 0.51 0.47 0.47
Working Capital Turnover Ratio
 -14.67 56.83 7.16 -233.66 67.39
Cash Conversion Cycle
 136.11 133.27 150.87 145.11 156.03
Days of Sales Outstanding
 62.14 65.60 72.23 61.28 68.73
Days of Inventory Outstanding
 105.15 97.11 110.29 119.29 128.51
Days of Payables Outstanding
 31.18 29.44 31.65 35.47 41.21
Operating Cycle
 167.29 162.71 182.52 180.58 197.24
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 0.04 0.05 0.04
Free Cash Flow Per Share
 -0.03 -0.03 0.02 0.02 0.02
CapEx Per Share
 0.03 0.03 0.02 0.03 0.02
Free Cash Flow to Operating Cash Flow
 4.19 8.48 0.44 0.43 0.40
Dividend Paid and CapEx Coverage Ratio
 -0.31 -0.13 1.80 1.39 1.16
Capital Expenditure Coverage Ratio
 -0.31 -0.13 1.80 1.76 1.68
Operating Cash Flow Coverage Ratio
 -0.01 >-0.01 0.06 0.09 0.06
Operating Cash Flow to Sales Ratio
 -0.01 >-0.01 0.06 0.10 0.07
Free Cash Flow Yield
-6.20%-3.52%3.98%3.73%1.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -82.09 -42.27 -31.14 345.44 57.54
Price-to-Sales (P/S) Ratio
 0.96 1.46 0.71 1.12 1.44
Price-to-Book (P/B) Ratio
 1.34 2.09 1.12 1.42 1.83
Price-to-Free Cash Flow (P/FCF) Ratio
 -16.43 -28.37 25.10 26.80 51.76
Price-to-Operating Cash Flow Ratio
 -68.90 -240.48 11.15 11.59 20.88
Price-to-Earnings Growth (PEG) Ratio
 -0.68 -0.90 0.04 -3.98 -3.04
Price-to-Fair Value
 1.34 2.09 1.12 1.42 1.83
Enterprise Value Multiple
 151.85 -281.27 28.13 17.97 27.36
Enterprise Value
 11.49B 13.90B 9.49B 11.23B 12.85B
EV to EBITDA
 150.59 -281.27 28.13 17.97 27.36
EV to Sales
 2.08 2.57 1.72 2.11 2.44
EV to Free Cash Flow
 -35.70 -50.04 60.42 50.49 87.58
EV to Operating Cash Flow
 -149.72 -424.12 26.83 21.83 35.33
Tangible Book Value Per Share
 0.07 0.05 <0.01 0.06 0.06
Shareholders’ Equity Per Share
 0.41 0.39 0.37 0.44 0.43
Tax and Other Ratios
Effective Tax Rate
 1.88 -9.46 -0.38 0.75 0.36
Revenue Per Share
 0.57 0.56 0.57 0.55 0.55
Net Income Per Share
 >-0.01 -0.02 -0.01 <0.01 0.01
Tax Burden
 -0.68 10.46 1.38 0.25 0.64
Interest Burden
 -8.68 0.13 -0.37 0.18 0.56
Research & Development to Revenue
 0.02 0.06 0.05 0.03 0.03
SG&A to Revenue
 0.10 0.11 0.04 0.02 0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.19 0.18 -2.79 29.81 1.78
Currency in HKD